Nutra Pharma owns 11 patents for the test kit technology.
These patents provide for the protection and exclusive
use of the paraffin-baiting system and detection
systems.
METHOD FOR SPECIATING AND IDENTIFYING MAI
(MYCOBACTERIUM AVIUM-INTRACELLULARE) |
| |
METHOD AND APPARATUS FOR TESTING MAI (MYCOBACTERIUM
AVIUM-INTRACELLULARE) FOR ANTIMICROBIAL AGENT
SENSITIVITY |
| |
APPARATUS FOR DETERMINING THE PRESENCE OR
ABSENCE OF MAI (MYCOBACTERIUM AVIUM-INTRACELLULARS) |
| |
APPARATUS FOR TESTING MAI (MYCOBACTERIUM AVIUM-INTRACELLULARE)
FOR ANTIMICROBIAL AGENT SENSITIVITY |
| |
METHOD OF TESTING A BODY SPECIMEN TAKEN FROM
A PATIENT FOR THE PRESENCE OR ABSENCE OF A
MICROORGANISM A FURTHER ASSOCIATED METHOD
AND ASSOCIATED APPARATUS |
METHOD FOR DETERMINING A PRESENCE OR ABSENCE
OF A NONPARAFFINOPHILIC HYDROPHOBIC MICROORGANISM
IN A BODY SPECIMEN AND AN ASSOCIATED APPARATUS |
APPARATUS FOR TESTING PARAFFINOPHILIC MICROORGANISMS
FOR ANTIMICROBIAL SENSITIVITY |
| |
APPARATUS FOR DETERMINING THE PRESENCE OR
ABSENCE OF A NONPARAFFINOPHILIC MICROORGANISM |
| |
METHOD AND APPARATUS FOR SPECIATING AND IDENTIFYING
MAI (MYCOBACTERIUM AVIUM-INTRACELLULARE) AND
TESTING THE SAME FOR ANTIBIOTIC SENSITIVITY |
| |
METHOD FOR DETERMINING A PRESENCE OR ABSENCE
OF A NONPARAFFINOPHILIC HYDROPHOBIC MICROORGANISM
IN A BODY SPECIMEN BY USING A DNA EXTRACTION
PROCEDURE AND A NOVEL DNA EXTRACTION PROCEDURE |
| |
METHOD OF DETERMINING THE ANTIMICROBIAL AGENT
SENSITIVITY OF A NONPARAFFINOPHILIC HYDROPHOBIC
MICROORGANISM AND AN ASSOCIATED APPARATUS |
